Clinical Report: FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure

Overview

Revise to remove unsupported claims and ensure all statements are directly sourced.

Background

Remove subjective language regarding the importance of postexposure prophylaxis.

Data Highlights

Key Findings

• Ensitrelvir reduced the risk of symptomatic COVID-19 by 67% compared to placebo.
• The primary analysis included 2,041 participants with negative SARS-CoV-2 tests at baseline.
• Participants began treatment within 72 hours of symptom onset in the household member.
• Common adverse events included headache, diarrhea, and cough, with similar rates in both treatment groups.
• Ensitrelvir is administered as a 5-day regimen.

Clinical Implications

Ensitrelvir provides a new oral option for postexposure prophylaxis against COVID-19, which may be particularly beneficial in household and high-risk settings. Clinicians should consider this treatment for eligible patients following exposure to COVID-19.

Conclusion

The approval of ensitrelvir marks a significant advancement in the prevention of COVID-19 following exposure, offering a new tool for healthcare providers in managing potential outbreaks.

Related Resources & Content

1. Shionogi, New England Journal of Medicine, 2026 -- FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure
2. conexiant — Ensitrelvir Reduced COVID After Household Exposure
3. Infection — Assessment of Ensitrelvir's Effectiveness and Safety in Patients with Asymptomatic or Mild to Moderate COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
4. The ASCO Post — FDA Issues Emergency Use Authorization for Remdesivir for Treatment of Severe COVID-19
5. conexiant — Two-Drug HIV Regimen Gains FDA Approval
6. Shionogi Announces FDA Approval of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure
7. New England Journal of Medicine Publishes Shionogi Study Demonstrating Ensitrelvir Prevents COVID-19 Following Exposure | Shionogi Inc.
8. Types of COVID-19 Treatment | Covid | CDC